Clinical Trial Update: Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study update for BCD-115 in women with ER-positive, HER2-negative locally advanced or metastatic breast cancer; the trial status is reported as complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BCD-115

Snippet

Sponsor: Biocad | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED